Pharma's Almanac: Nice Insight's Content Community

Optimized Residual dsRNA Detection for mRNA Therapeutics

RNA

Optimized Residual dsRNA Detection for mRNA Therapeutics

A team of experts from Samsung Biologics discusses the company’s development of a superior ELISA-based method for dsRNA detection that ensures greater accuracy and reliability.

MegaBulb DNA: a Non-Viral ssDNA Breakthrough Revolutionizing Gene Editing

Gene Editing

MegaBulb DNA: a Non-Viral ssDNA Breakthrough Revolutionizing Gene Editing

Touchlight’s Elena Stoyanova, Ph.D., and Tom Adie, Ph.D., explain how the company’s new nonviral MegaBulb DNA (mbDNA) offers a high-purity, synthetic CRISPR ssDNA template that demonstrates remarkable efficiency and minimal toxicity.

Development Strategies for Overcoming Commercialization Challenges

Commercialization

Development Strategies for Overcoming Commercialization Challenges

Coriolis Pharma’s Matthias Lucke, Ph.D., discusses how a seamless integration of services that accelerates drug development while mitigating risks associated with transitions between different development phases ensures a streamlined path to market.

Economic Benefits of Digital Process Development

Process Development

Economic Benefits of Digital Process Development

DataHow’s Fabian Feidl, Ph.D., discusses how advanced digital tools and strategies, including quality-by-design, hybrid modeling, transfer learning, and digital twins, not only enhance efficiency in process development but also substantially cut costs in manufacturing.

Developing a Toolbox of Functional Bioassays for Optimizing ADCC

Bioassays

Developing a Toolbox of Functional Bioassays for Optimizing ADCC

Tanvex CDMO’s Anke Hartung, Ph.D., discusses her team’s development of novel analytical tools to assess the enhancement of the antibody-dependent cellular cytoxicity response of an anticancer monoclonal antibody drug.

Revolutionizing Autoimmune Disease Management with Soluble Bispecific Receptors

Biopharma

Revolutionizing Autoimmune Disease Management with Soluble Bispecific Receptors

Fab Biopharma’s Reiner Getz, Ph.D., and Gardiner Smith, J.D. discuss how the company aims to revolutionize the treatment of complex and often life-threatening autoimmune diseases like Sjögren’s disease and lupus with its groundbreaking soluble bispecific receptor therapies

The Shift from Early- to Late-Phase Ophthalmology Retina Market in 2024: Proactive Planning for Late-Stage Clinical Success

Ophthalmology

The Shift from Early- to Late-Phase Ophthalmology Retina Market in 2024: Proactive Planning for Late-Stage Clinical Success

Tracey Roberts, Jennifer Christiansen, Ph.D., and Debra Schaumberg, Sc.D., O.D., all with the PPD™ clinical research business of Thermo Fisher Scientific, discuss the growth and challenges of global, late-stage ophthalmology clinical trials and the key drivers of proactive planning for success.

Agile Cell Supply and Processing to Accelerate Development of the Medicines of the Future

Cell Therapy

Agile Cell Supply and Processing to Accelerate Development of the Medicines of the Future

In this Q&A, OrganaBio’s Chief Executive Officer Justin Irizarry discusses the strategies and operational philosophies driving the company and how it plans to navigate future challenges and opportunities in the rapidly evolving cell therapy landscape.

Most Read

Optimized Residual dsRNA Detection for mRNA Therapeutics

RNA

Optimized Residual dsRNA Detection for mRNA Therapeutics

Transforming the Economics of AAV Manufacture While Optimizing Quality with dbDNA

Synthetic DNA

Transforming the Economics of AAV Manufacture While Optimizing Quality with dbDNA

DoE for Clone Selection and Process Development to Meet Biosimilar Critical Qualities Attributes and High Productivity

Biosimilars

DoE for Clone Selection and Process Development to Meet Biosimilar Critical Qualities Attributes and High Productivity

News

The Road to the Max: Australia

The Road to the Max: Australia

Editor's Pick

Top 5

#1

dbDNA

Revolutionizing the Genetic Medicine Landscape with Enzymatic DNA

#2

#3

#4

#5

Top 5

#1

#2

#3

#4

Female-Centric

Sep 10, 2024

Transforming Drug Development through a Female Perspective

#5

RoundTable

View all roundtable

RoundTable

View all roundtable

Now Trending

Videos

View all videos

Immuno-Oncology

Building Multiple Platforms to Address Difficult-to-Treat Cancers

On the Road to 50 States, Derek Hennecke, Investor at Inceptor Bio, talks to Nigel about what attracted him to Inceptor Bio and the technologies which Inceptor Bio are currently focusing on.

Building Multiple Platforms to Address Difficult-to-Treat Cancers

Immuno-Oncology

May 24, 2022

Building Multiple Platforms to Address Difficult-to-Treat Cancers

Assembling the Crew

Meet the Crew

Aug 07, 2024

Assembling the Crew

Transforming Market Insights into Growth

Marketing

May 09, 2022

Transforming Market Insights into Growth

Sailing into the Trade Winds

Setting Sail

Aug 07, 2024

Sailing into the Trade Winds

The Power of Aqueous Detergents in Critical Cleaning

Aqueous Cleaning

Dec 05, 2023

The Power of Aqueous Detergents in Critical Cleaning

Growing as a Trusted, Dedicated Commercial Biologics CDMO

Biologics CDMO

Jan 26, 2022

Growing as a Trusted, Dedicated Commercial Biologics CDMO

Disaster Strikes

Failure to Launch

Aug 07, 2024

Disaster Strikes

Preparing the Yacht for the Race

Preparing to Launch

Aug 07, 2024

Preparing the Yacht for the Race

Discussing the Advancements in Oncology

Data Connectivity

Jan 19, 2022

Discussing the Advancements in Oncology

The Evolving Role of Remote Monitoring

Decentralized Clinical Trials

Nov 17, 2022

The Evolving Role of Remote Monitoring

Rethinking the Pharma/Biopharma Supply Chain to Maximize Resilience

Supply Chain

Dec 12, 2023

Rethinking the Pharma/Biopharma Supply Chain to Maximize Resilience

Designing A Recipe for Stem Cell Therapy Success

Stem Cell Therapy

Dec 12, 2023

Designing A Recipe for Stem Cell Therapy Success

Latest

View all latest

Areas of Interests

Academia CDMO Clinical CRO Drug Discovery Early R&D Excipients / Intermediates Financing Equipment Preclinical CRO Supply Chain Technology

A comprehensive market analysis with 110 major company profiles and detailed CDMO pricing information.

A comprehensive market analysis with 110 major company profiles and detailed CDMO pricing information.

Over 60 company profiles covering the leading mRNA and LNP contract manufacturing organizations. Unique pricing comparison for the end-to-end manufacturing process.

Over 60 company profiles covering the leading mRNA and LNP contract manufacturing organizations. Unique pricing comparison for the end-to-end manufacturing process.

Optimize your manufacturing process using 50+ established CDMO overviews and a requisite pricing study for small, mid sized and large manufacturers.

Optimize your manufacturing process using 50+ established CDMO overviews and a requisite pricing study for small, mid sized and large manufacturers.

Comprehensive analysis of mammalian cell culture CDMOs including price benchmarking, market trends and over 80 company profiles.

Comprehensive analysis of mammalian cell culture CDMOs including price benchmarking, market trends and over 80 company profiles.

Over 80 company profiles and analysis of leading microbial fermentation CDMO; exclusive market analysis and price comparison.

Over 80 company profiles and analysis of leading microbial fermentation CDMO; exclusive market analysis and price comparison.

Understand the emerging ADC market with profiles on 30 notable CDMOs and an analysis of the value chain of mAbs, linkers and payloads. Benchmark with robust manufacturing pricing.

Understand the emerging ADC market with profiles on 30 notable CDMOs and an analysis of the value chain of mAbs, linkers and payloads. Benchmark with robust manufacturing pricing.

Exclusive pricing from 20+ CDMOs and market insight for pDNA as a reagent for advanced therapies and as a primary therapeutic.

Exclusive pricing from 20+ CDMOs and market insight for pDNA as a reagent for advanced therapies and as a primary therapeutic.

Robust analysis of gene therapy market, includes 50 company profiles of AAV, Lentiviral and non-viral gene therapy CDMOs.

Robust analysis of gene therapy market, includes 50 company profiles of AAV, Lentiviral and non-viral gene therapy CDMOs.

Discover the cell therapy market with unique insights, analysis, and overviews of allogeneic and autologous cell therapy CDMOs.

Discover the cell therapy market with unique insights, analysis, and overviews of allogeneic and autologous cell therapy CDMOs.

Over 80 extensive CDMO profiles for an all-encompassing benchmarking report. Exclusive pricing comparison and updated global GMP regulatory landscape

Over 80 extensive CDMO profiles for an all-encompassing benchmarking report. Exclusive pricing comparison and updated global GMP regulatory landscape

Discover the cell therapy market with unique insights, analysis, and overviews of allogeneic and autologous cell therapy CDMOs.

Discover the cell therapy market with unique insights, analysis, and overviews of allogeneic and autologous cell therapy CDMOs.

Roads to

road to 50 states images

road to 50 states images

road to 50 states images

road to 50 states images

road to 50 states images

road to 50 states images

road to 50 states images

road to 50 states images

road to 50 states images

road to 50 states images

road to 2021 images

road to 2021 images

road to 2021 images

road to 2021 images

road to 2021 images

road to 2021 images

road to 2021 images

road to 2021 images

road to 2021 images

road to 2021 images

road to bio images

road to bio images

road to bio images

road to bio images

road to bio images

road to bio images

road to bio images

road to bio images

road to bio images

road to bio images

road to ireland images

road to ireland images

road to ireland images

road to ireland images

road to ireland images

road to ireland images

road to ireland images

road to ireland images

road to ireland images

road to ireland images

road to launch images

road to launch images

road to launch images

road to launch images

road to launch images

road to launch images

road to launch images

road to launch images

road to launch images